Insulet Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Insulet
PODD Stock  USD 287.70  1.21  0.42%   
Insulet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insulet's valuation are provided below:
Gross Profit
1.8 B
Profit Margin
0.0976
Market Capitalization
20.3 B
Enterprise Value Revenue
8.1276
Revenue
2.5 B
There are over one hundred nineteen available fundamental trends for Insulet, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Insulet's regular performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.8 B. The current year's Enterprise Value is expected to grow to about 10.5 B

Insulet Total Revenue

2.5 Billion

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 51.6 M, Other Operating Expenses of 2.1 B or Operating Income of 373 M, as well as many indicators such as Price To Sales Ratio of 15.94, Dividend Yield of 0.0 or PTB Ratio of 19.9. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
Build AI portfolio with Insulet Stock
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.7 B3.6 B1.4 B
Slightly volatile
Cash1.2 B1.1 B465.3 M
Slightly volatile
Other Assets1.091.1524.1 M
Pretty Stable
Cash And Short Term Investments1.2 B1.1 B489.1 M
Slightly volatile
Common Stock Shares Outstanding46.3 M85 M57.8 M
Slightly volatile
Liabilities And Stockholders Equity3.7 B3.6 B1.4 B
Slightly volatile
Total Liabilities2.3 B2.2 B969.3 M
Slightly volatile
Total Current Assets2.3 B2.2 B854.9 M
Slightly volatile
Short and Long Term Debt Total1.7 B1.6 B769.7 M
Slightly volatile
Total Current Liabilities638 M607.7 M215.9 M
Slightly volatile
Short Term Debt52.6 M98.8 M57.3 M
Pretty Stable
Property Plant And Equipment Net917.5 M873.8 M344.5 M
Slightly volatile
Accounts Payable19.8 M22.8 M23.1 M
Slightly volatile
Non Current Assets Total1.5 B1.4 B543 M
Slightly volatile
Non Currrent Assets Other192.5 M183.3 M68.5 M
Slightly volatile
Common Stock Total Equity120.8 K115 K75 K
Slightly volatile
Non Current Liabilities Total1.6 B1.5 B755.3 M
Slightly volatile
Property Plant And Equipment Gross1.3 B1.2 B447.2 M
Slightly volatile
Common Stock61.9 K115 K71.5 K
Slightly volatile
Other Liabilities5.4 M9.5 M6.6 M
Slightly volatile
Long Term Debt1.6 B1.5 B731.7 M
Slightly volatile
Net Receivables441.3 M420.3 M144.2 M
Slightly volatile
Inventory519.7 M495 M173.9 M
Slightly volatile
Property Plant Equipment724.4 M689.9 M306.1 M
Slightly volatile
Good Will45 M59.2 M41.4 M
Slightly volatile
Long Term Debt Total1.7 B1.6 B754 M
Slightly volatile
Capital Surpluse899.1 M1.2 B852.8 M
Slightly volatile
Non Current Liabilities Other62.3 M59.3 M19.7 M
Slightly volatile
Intangible Assets118.9 M113.3 M41.9 M
Slightly volatile
Capital Lease Obligations230 K242.1 K1.6 M
Slightly volatile
Short and Long Term Debt129.8 M86.4 M140.3 M
Slightly volatile
Net Invested Capital1.6 B3 B1.2 B
Slightly volatile
Net Working Capital937.2 M1.6 B734 M
Slightly volatile
Capital Stock103.6 K115 K79.4 K
Slightly volatile

Insulet Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.1 B2 B818 M
Slightly volatile
Research Development265.2 M252.5 M113.5 M
Slightly volatile
Total Operating Expenses1.4 B1.3 B511.2 M
Slightly volatile
Selling And Marketing Expenses74.5 M96.9 M75.1 M
Slightly volatile
Depreciation And Amortization97.6 M92.9 M38.3 M
Slightly volatile
Selling General Administrative1 B957.8 M325.8 M
Slightly volatile
Total Revenue2.5 B2.4 B897.5 M
Slightly volatile
Cost Of Revenue755.8 M719.8 M306.9 M
Slightly volatile
Interest Income47.7 M45.4 M16.7 M
Slightly volatile
Reconciled Depreciation52.9 M92.9 M36.9 M
Slightly volatile

Insulet Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow850.3 M809.8 M365.4 M
Slightly volatile
Depreciation97.6 M92.9 M38.3 M
Slightly volatile
Capital Expenditures150.8 M143.6 M84 M
Slightly volatile
End Period Cash Flow1.2 B1.1 B450.6 M
Slightly volatile
Change To Liabilities158.8 M151.2 M51.9 M
Slightly volatile
Stock Based Compensation83.7 M79.7 M34.6 M
Slightly volatile
Change To Netincome40.7 M55.1 M38 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.9410.1615.5305
Slightly volatile
Days Sales Outstanding73.4474.0659.2739
Pretty Stable
Stock Based Compensation To Revenue0.0590.03850.0526
Slightly volatile
Capex To Depreciation3.231.783.0488
Very volatile
EV To Sales18.2110.4218.5129
Slightly volatile
Inventory Turnover1.591.674.6528
Slightly volatile
Days Of Inventory On Hand237226150
Slightly volatile
Payables Turnover29.8728.4513.395
Slightly volatile
Research And Ddevelopement To Revenue0.120.10612.7911
Slightly volatile
Capex To Revenue0.06590.06936.5339
Slightly volatile
Cash Per Share16.2715.6510.8899
Very volatile
Days Payables Outstanding12.6113.2857.3145
Slightly volatile
Intangibles To Total Assets0.05310.05590.1139
Slightly volatile
Current Ratio3.874.0727.2628
Slightly volatile
Receivables Turnover4.985.16.8423
Very volatile
Graham Number45.5443.3711.7468
Slightly volatile
Capex Per Share3.182.051.9046
Very volatile
Average Receivables24.6 M29.9 M31.6 M
Very volatile
Revenue Per Share27.9426.6112.7023
Slightly volatile
Interest Debt Per Share19.7518.8111.5398
Slightly volatile
Debt To Assets0.420.410.5473
Pretty Stable
Operating Cycle269363263
Very volatile
Days Of Payables Outstanding12.6113.2857.3145
Slightly volatile
Ebt Per Ebit1.571.121.4131
Slightly volatile
Quick Ratio2.983.1426.6588
Slightly volatile
Net Income Per E B T1.051.60.9938
Very volatile
Cash Ratio1.972.0725.5236
Slightly volatile
Cash Conversion Cycle201349202
Pretty Stable
Days Of Inventory Outstanding237226150
Slightly volatile
Days Of Sales Outstanding73.4474.0659.2739
Pretty Stable
Fixed Asset Turnover4.413.144.2792
Slightly volatile
Debt Ratio0.420.410.5473
Pretty Stable
Price Sales Ratio15.9410.1615.5305
Slightly volatile
Asset Turnover0.460.60.6576
Pretty Stable

Insulet Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.8 B9.3 B7.1 B
Slightly volatile
Enterprise Value10.5 B10 B7.6 B
Slightly volatile

Insulet Fundamental Market Drivers

Forward Price Earnings47.1698
Cash And Short Term Investments953.4 M

Insulet Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue13.8 M14.5 M
Total Revenue2.4 B2.5 B
Cost Of Revenue719.8 M755.8 M
Stock Based Compensation To Revenue 0.04  0.06 
Research And Ddevelopement To Revenue 0.11  0.12 
Capex To Revenue 0.07  0.07 
Revenue Per Share 26.61  27.94 
Ebit Per Revenue 0.13  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
How To Invest In Insulet
Details
Is Insulet Stock a good investment?
Details
What is Insulet's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.148
Earnings Share
3.42
Revenue Per Share
35.873
Quarterly Revenue Growth
0.299
Return On Assets
0.0874
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY